Bone marrow injection further benefits core decompression treatment for osteonecrosis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Combining Concentrated Autologous Bone Marrow Stem Cells Injection With Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study
J Arthroplasty. 2015 Sep;30(9 Suppl):11-518 patients (28 hips) with early-stage osteonecrosis of the femoral head (ONFH) were randomly assigned to receive core decompression with or without an autologous bone marrow stem cell injection. The purpose of this study was to investigate the clinical effects of concentrated bone marrow injection when used in combination with core decompression, and observe its effects on disease progression. The combined treatment resulted in a significantly greater improvement in both VAS pain and WOMAC scores when compared to core decompression alone. The use of bone marrow injection also demonstrated greater benefit in slowing or reversing disease progression (as assessed by MRI) compared to core decompression surgery alone.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
